Frontiers in Psychiatry | Psychopharmacology

Original Research

Published on 30 Jun 2023

EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors

in Psychopharmacology

Beth Youngblood
Julio C. Medina
Donald R. Gehlert
Neil Schwartz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1170541

5,107 views
1 citation

Case Report

Published on 29 Jun 2023

Case report: Treatment-resistant schizophrenia with auto-aggressive compulsive behavior—Successful management with cariprazine

in Psychopharmacology

Lubova Renemane
Elmars Rancans

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1209077

5,477 views
1 citation

Systematic Review

Published on 27 Jun 2023

Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis

in Psychopharmacology

Yarmila Elena Valencia Carlo
Ricardo Arturo Saracco-Alvarez
Verónica Angela Valencia Carlo
Daniela Vázquez Vega
Guillermina Natera Rey
Raul Ivan Escamilla Orozco

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1189768

17,354 views
6 citations

Systematic Review

Published on 26 Jun 2023

Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder

in Psychopharmacology

Angela N. Phan
Garth E. Terry

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1144276

9,245 views
1 citation

Review

Published on 26 Jun 2023

Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review

in Psychopharmacology

Simon Zhornitsky
Henrique N. P. Oliva
Laura A. Jayne
Aza S. A. Allsop
Alfred P. Kaye
Marc N. Potenza
Gustavo A. Angarita

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1197890

10,172 views
8 citations

Original Research

Published on 22 Jun 2023

Cariprazine for negative symptoms in early psychosis: a pilot study with a 6-month follow-up

in Psychopharmacology

Sofia Pappa
Arturas Kalniunas
Jose Maret

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1183912

4,335 views
5 citations

Original Research

Published on 16 Jun 2023

Psychedelics and workplace harm

in Psychopharmacology

Sean Matthew Viña
Amanda Layne Stephens

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1186541

4,294 views
17 citations

Original Research

Published on 15 Jun 2023

Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the COVID-19 pandemic

in Psychopharmacology

Maria Bălăeț
William Trender
Peter J. Hellyer
Adam Hampshire

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1184681

13,438 views
8 citations

Review

Published on 12 Jun 2023

Psychedelic therapy in the treatment of addiction: the past, present and future

in Psychopharmacology

Rayyan Zafar
Maxim Siegel
Rebecca Harding
Tommaso Barba
Claudio Agnorelli
Shayam Suseelan
Leor Roseman
Matthew Wall
David John Nutt
David Erritzoe

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1183740

57,282 views
51 citations

Correction

Published on 06 Jun 2023

Corrigendum: Flurbiprofen used in one-lung ventilation improves intraoperative regional cerebral oxygen saturation and reduces the incidence of postoperative delirium

in Psychopharmacology

Liang Shen
Jia-qi Chen
Xin-lu Yang
Ji-cheng Hu
Wei Gao
Xiao-qing Chai
Di Wang

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1228369

1,052 views

Original Research

Published on 02 Jun 2023

Historical developments, hotspots, and trends in tardive dyskinesia research: a scientometric analysis of 54 years of publications

in Psychopharmacology

Anuradha Baminiwatta
Christoph U. Correll

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1194222

5,372 views
5 citations

Review

Published on 02 Jun 2023

Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants

in Psychopharmacology

Christian Yavorsky
Elizabeth Ballard
Mark Opler
Jan Sedway
Steven D. Targum
William Lenderking

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1135828

5,169 views
3 citations

Original Research

Published on 25 May 2023

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

in Psychopharmacology

María del Mar Cajiao-Manrique
Verònica Casadó-Anguera
Alejandra García-Blanco
Rafael Maldonado
Elena Martín-García

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1148993

4,209 views
2 citations

Original Research

Published on 19 May 2023

Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial

in Psychopharmacology

Mengling Deng
Zhi Yang
Yanfei Ni
Lingli Zhu
Jiating Xu
Lifeng Zheng
Bo Zhou

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1142419

2,342 views
1 citation

Original Research

Published on 18 May 2023

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system

in Psychopharmacology

Tigran Makunts
Diane Dahill
Lisa Jerome
Alberdina de Boer
Ruben Abagyan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1149766

4,505 views
4 citations

Case Report

Published on 15 May 2023

Case report: Intramuscular ketamine or intranasal esketamine as a treatment in four patients with major depressive disorder and comorbid anorexia nervosa

in Psychopharmacology

Johanna Louise Keeler
Janet Treasure
Hubertus Himmerich
Madeline Brendle
Claire Moore
Reid Robison

Frontiers in Psychiatry

doi 10.3389/fpsyt.2023.1181447

4,514 views
21 citations